• Something wrong with this record ?

Pulsed Field Ablation to Treat Atrial Fibrillation: Autonomic Nervous System Effects

DR. Musikantow, P. Neuzil, J. Petru, JS. Koruth, S. Kralovec, MA. Miller, M. Funasako, M. Chovanec, MK. Turagam, W. Whang, L. Sediva, SR. Dukkipati, VY. Reddy

. 2023 ; 9 (4) : 481-493. [pub] 20221130

Language English Country United States

Document type Journal Article

BACKGROUND: During atrial fibrillation ablations using thermal energy, the treatment effect is attributed to not just pulmonary vein isolation (PVI), but also to modulation of the autonomic nervous system by ablation of cardiac ganglionated plexi (GP). OBJECTIVES: This study sought to assess the impact of pulsed field ablation (PFA) on the GP in patients undergoing PVI. METHODS: In the retrospective phase, heart rate was assessed pre- versus post-PVI using PFA, cryoballoon ablation, or radiofrequency ablation. In the prospective phase, a pentaspline PFA catheter was used in a protocol: 1) pre-PFA, high-frequency stimulation (HFS) identified GP sites by vagal effects; 2) PVI was performed assessing for repetitive vagal effects over each set of PF applications; 3) mapping defined PVI extent to identify those GP in the ablation zone; and 4) repeat HFS at GP sites to assess for persistence of vagal effects. RESULTS: Between baseline and 3 months, heart rates in the retrospective radiofrequency ablation (n = 40), cryoballoon (n = 40), and PFA (n = 40) cohorts increased by 8.9 ± 11.4, 11.1 ± 9.4, and -0.1 ± 9.2 beats/min, respectively (P= 0.01 PFA vs radiofrequency ablation; P= 0.01 PFA vs cryoballoon ablation). In the prospective phase, pre-PFA HFS in 20 additional patients identified 65 GP sites. During PFA, vagal effects were noted in 45% of first PF applications, persisting through all applications in 83%. HFS post-PFA reproduced vagal effects in 29 of 38 sites (76%) in low-voltage tissue. CONCLUSIONS: PFA has minimal effect on GP. Unlike with thermal ablation, the mechanism by which PFA treats atrial fibrillation is mediated solely by durable PVI.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010562
003      
CZ-PrNML
005      
20230801132510.0
007      
ta
008      
230718s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jacep.2022.10.028 $2 doi
035    __
$a (PubMed)36752473
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Musikantow, Daniel R $u Icahn School of Medicine at Mount Sinai, New York, New York, USA
245    10
$a Pulsed Field Ablation to Treat Atrial Fibrillation: Autonomic Nervous System Effects / $c DR. Musikantow, P. Neuzil, J. Petru, JS. Koruth, S. Kralovec, MA. Miller, M. Funasako, M. Chovanec, MK. Turagam, W. Whang, L. Sediva, SR. Dukkipati, VY. Reddy
520    9_
$a BACKGROUND: During atrial fibrillation ablations using thermal energy, the treatment effect is attributed to not just pulmonary vein isolation (PVI), but also to modulation of the autonomic nervous system by ablation of cardiac ganglionated plexi (GP). OBJECTIVES: This study sought to assess the impact of pulsed field ablation (PFA) on the GP in patients undergoing PVI. METHODS: In the retrospective phase, heart rate was assessed pre- versus post-PVI using PFA, cryoballoon ablation, or radiofrequency ablation. In the prospective phase, a pentaspline PFA catheter was used in a protocol: 1) pre-PFA, high-frequency stimulation (HFS) identified GP sites by vagal effects; 2) PVI was performed assessing for repetitive vagal effects over each set of PF applications; 3) mapping defined PVI extent to identify those GP in the ablation zone; and 4) repeat HFS at GP sites to assess for persistence of vagal effects. RESULTS: Between baseline and 3 months, heart rates in the retrospective radiofrequency ablation (n = 40), cryoballoon (n = 40), and PFA (n = 40) cohorts increased by 8.9 ± 11.4, 11.1 ± 9.4, and -0.1 ± 9.2 beats/min, respectively (P= 0.01 PFA vs radiofrequency ablation; P= 0.01 PFA vs cryoballoon ablation). In the prospective phase, pre-PFA HFS in 20 additional patients identified 65 GP sites. During PFA, vagal effects were noted in 45% of first PF applications, persisting through all applications in 83%. HFS post-PFA reproduced vagal effects in 29 of 38 sites (76%) in low-voltage tissue. CONCLUSIONS: PFA has minimal effect on GP. Unlike with thermal ablation, the mechanism by which PFA treats atrial fibrillation is mediated solely by durable PVI.
650    _2
$a lidé $7 D006801
650    12
$a fibrilace síní $7 D001281
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a prospektivní studie $7 D011446
650    12
$a katetrizační ablace $x škodlivé účinky $7 D017115
650    _2
$a nervus vagus $x chirurgie $7 D014630
655    _2
$a časopisecké články $7 D016428
700    1_
$a Neuzil, Petr $u Homolka Hospital, Prague, Czech Republic
700    1_
$a Petru, Jan $u Homolka Hospital, Prague, Czech Republic
700    1_
$a Koruth, Jacob S $u Icahn School of Medicine at Mount Sinai, New York, New York, USA
700    1_
$a Kralovec, Stepan $u Homolka Hospital, Prague, Czech Republic
700    1_
$a Miller, Marc A $u Icahn School of Medicine at Mount Sinai, New York, New York, USA
700    1_
$a Funasako, Mortioshi $u Homolka Hospital, Prague, Czech Republic
700    1_
$a Chovanec, Milan $u Homolka Hospital, Prague, Czech Republic
700    1_
$a Turagam, Mohit K $u Icahn School of Medicine at Mount Sinai, New York, New York, USA
700    1_
$a Whang, William $u Icahn School of Medicine at Mount Sinai, New York, New York, USA
700    1_
$a Sediva, Lucie $u Homolka Hospital, Prague, Czech Republic
700    1_
$a Dukkipati, Srinivias R $u Icahn School of Medicine at Mount Sinai, New York, New York, USA
700    1_
$a Reddy, Vivek Y $u Icahn School of Medicine at Mount Sinai, New York, New York, USA; Homolka Hospital, Prague, Czech Republic. Electronic address: vivek.reddy@mountsinai.org
773    0_
$w MED00193518 $t JACC. Clinical electrophysiology $x 2405-5018 $g Roč. 9, č. 4 (2023), s. 481-493
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36752473 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801132507 $b ABA008
999    __
$a ok $b bmc $g 1963155 $s 1196827
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 9 $c 4 $d 481-493 $e 20221130 $i 2405-5018 $m JACC. Clinical electrophysiology $n JACC Clin Electrophysiol $x MED00193518
LZP    __
$a Pubmed-20230718

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...